Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
Stefano de Biase,1 Mariarosaria Valente,1,2 Gian Luigi Gigli1,21Neurology Unit, Department of Experimental and Clinical Medical Sciences, University of Udine Medical School, 2Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, ItalyAbstract: Restless legs syndrome...
Guardado en:
Autores principales: | de Biase S, Valente M, Gigli GL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dc949b9b5cc94a8facd797f64a976ef7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
por: Lazzari M, et al.
Publicado: (2016) -
Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study
por: Petrò E, et al.
Publicado: (2016) -
Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report
por: Guerriero F, et al.
Publicado: (2015) -
The Safety and Efficacy of Pregabalin Add-on Therapy in Restless Legs Syndrome Patients
por: Hyoeun Bae, et al.
Publicado: (2021) -
Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: two case reports
por: Ughi N, et al.
Publicado: (2016)